-
ECONOMIC ANALYSES OF GENDER-AFFIRMING CARE: A LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
DRIVERS OF MOBILE PATIENT PORTAL APP USE: INSIGHTS FOR IMPLEMENTATION AND VALUE-BASED DECISION-MAKING
Mar 18, 2026, 21:38 PM -
RETHINKING HEALTH ECONOMIC MODELS FOR OUTCOME-ALIGNED PAYMENTS: A FRAMEWORK FOR THE NEW 2026 CMS ACCESS MODEL
Mar 18, 2026, 21:38 PM -
INCIDENCE AND RISK FACTORS FOR SEXUALLY TRANSMITTED DISEASES FOLLOWING SOLID ORGAN TRANSPLANT, HEMATOPOIETIC STEM CELL TRANSPLANTATION, AND CAR T-CELL THERAPY
Mar 18, 2026, 21:38 PM -
REAL WORLD INSIGHTS INTO OBESITY CARE: UNDERSTANDING TREATMENT PATTERNS AND PAYER COSTS AT AN INTEGRATED HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF MOBILE CLINICS COMPARED TO FIXED HEALTH FACILITIES IN DELIVERING PRIMARY HEALTHCARE SERVICES IN INTERNALLY DISPLACED PERSONS CAMPS IN NORTHEASTERN NIGERIA
Mar 18, 2026, 21:38 PM -
SPILLOVER EFFECTS OF US MFN POLICY ON EUROPEAN DRUG ACCESS
Mar 18, 2026, 21:38 PM -
IMPACT OF PD-1 AND PD-L1 INHIBITORS ON PATIENT-REPORTED OUTCOMES IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SYSTEMATIC REVIEW OF CLINICAL TRIALS
Mar 18, 2026, 21:38 PM -
REAL-WORLD CLINICAL CHARACTERISTICS AND FACTORS ASSOCIATED WITH CONCURRENT GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1 RA) THERAPY AMONG PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) PRESCRIBED RESMETIROM
Mar 18, 2026, 21:38 PM -
A SYSTEMATIC LITERATURE REVIEW ON FINANCIAL BURDEN, FINANCIAL TOXICITY, OUTCOMES, POTENTIAL INTERVENTIONS, AND POLICIES ASSOCIATED WITH OUT-OF-POCKET MEDICATION AND HEALTHCARE EXPENSES AMONG OLDER PATIENTS IN THE US
Mar 18, 2026, 21:38 PM -
OPERATING ROOM EFFICIENCY AND COST IMPLICATIONS OF THULIUM FIBER LASER VERSUS HOLMIUM:YAG LASER FOR PROSTATE ENUCLEATION: A TARGETED REVIEW, ANALYSIS, AND MODEL
Mar 18, 2026, 21:38 PM -
BARRIERS TO HEALTHCARE USE AMONG ADOLESCENTS IN CONFLICT-AFFECTED IDP CAMPS IN NORTHEASTERN NIGERIA: REAL-WORLD EVIDENCE ON ACCESS, EQUITY, AND SERVICE DELIVERY COSTS
Mar 18, 2026, 21:38 PM -
COMPARABILITY OF OPEN AND CLOSED CLAIMS DATA FOR HEALTHCARE RESOURCE UTILIZATION ASSESSMENT IN ACUTE ISCHEMIC STROKE
Mar 18, 2026, 21:38 PM -
FROM MORTALITY TO MONEY: YEARS OF LIFE LOST AND THE ECONOMIC BURDEN OF CYSTIC FIBROSIS IN COLOMBIA (2005-2023)
Mar 18, 2026, 21:38 PM -
REAL WORLD HEALTHCARE RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH PANCREATIC CANCERIN THE BRAZILIAN PRIVATE MARKET
Mar 18, 2026, 21:38 PM -
WHEN HYPERTENSION REACHES THE HOSPITAL: PROFILING PATIENTS ADMITTED WITH HYPERTENSION AS A PRIMARY DIAGNOSIS IN CHILE’S PUBLIC SECTOR
Mar 18, 2026, 21:38 PM -
AI/ML IN HTA EVIDENCE SYNTHESIS: WHERE DO WE STAND TODAY?
Mar 18, 2026, 21:38 PM -
HOSPITALIZATION PATTERNS AND RESOURCE UTILIZATION AT THE LVIV REGIONAL CLINICAL INFECTIOUS DISEASES HOSPITAL: A 2025 RETROSPECTIVE ANALYSIS
Mar 18, 2026, 21:38 PM -
DELAYS AND DENIALS FOR BRANDED MEDICATION FILLS DUE TO PRIOR AUTHORIZATION
Mar 18, 2026, 21:38 PM -
ASSESSING THE RELEVANCE OF HEALTH-RELATED QUALITY OF LIFE INSTRUMENTS AND PREFERENCE-BASED MEASURES FOR UTILITY GENERATION IN EARLY HD
Mar 18, 2026, 21:38 PM
